Literature DB >> 18084841

Individual delirium symptoms: do they matter?

François Marquis1, Sébastien Ouimet, Richard Riker, Mariève Cossette, Yoanna Skrobik.   

Abstract

OBJECTIVES: To evaluate the impact of individual manifestations of delirium on outcome, describe them in critically ill adults, and validate nurses' bedside item assessments from the Intensive Care Delirium Screening Checklist (ICDSC).
DESIGN: Prospective study.
SETTING: Single 16-bed medical/surgical university hospital intensive care unit. PATIENTS: Six hundred consecutive patients admitted to the intensive care unit for >24 hrs.
INTERVENTIONS: All patients were evaluated with the eight-item ICDSC throughout their intensive care unit stay. In all patients scoring positive on any ICDSC item, individual checklist items were tallied throughout the intensive care unit stay and assessed for impact on mortality. In addition, when the ICDSC score indicated delirium (> or = 4 of 8), the subsequent overall frequency of each item was also independently documented to describe delirious patient symptoms. ICDSC items were tested for discrimination between delirious and nondelirious patients. Throughout the study, the validity of bedside delirium assessments was assessed in 30 nurses.
MEASUREMENTS AND MAIN RESULTS: We were able to assess 537 patients. In nondelirious patients, psychomotor agitation by ICDSC assessment was associated with a higher risk of mortality after adjustment for Acute Physiology and Chronic Health Evaluation, age, and the presence of coma. One hundred eight-nine patients (35.1%) developed delirium (i.e., ICDSC score > or = 4). On presentation (and throughout the intensive care unit stay), the most frequent features of delirium were inattention, disorientation, and psychomotor agitation. Each ICDSC item was highly discriminating between delirious vs. nondelirious patients. Correlation between gold standard adjudicators and nurses for the overall bedside evaluations of delirium were excellent (Pearson's correlation R = 0.924, p < .0005). Individual symptom evaluation by nurses varied: Alteration in level of consciousness was poorest (R = 0.681, p < .0005), and both disorientation and hallucinations evaluated best (R = 1.000).
CONCLUSIONS: In nondelirious patients, agitation was associated with a higher risk of mortality. Each of the eight ICDSC items is highly discriminating for the diagnosis of delirium, suggesting that any screening or diagnostic scales should incorporate them. Quality assurance and educational efforts should, therefore, emphasize independent assessment of the individual features of delirium.

Entities:  

Mesh:

Year:  2007        PMID: 18084841     DOI: 10.1097/01.ccm.0000284506.43390.f3

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  12 in total

1.  The accurate recognition of delirium in the ICU: the emperor's new clothes?

Authors:  John W Devlin; Gilles L Fraser; Aaron M Joffe; Richard R Riker; Yoanna Skrobik
Journal:  Intensive Care Med       Date:  2013-10-11       Impact factor: 17.440

2.  Preoperative Risk Factors for Subsyndromal Delirium in Older Adults Who Undergo Joint Replacement Surgery.

Authors:  Dawn L Denny; Glenda Lindseth
Journal:  Orthop Nurs       Date:  2017 Nov/Dec       Impact factor: 0.913

3.  Prognostic Significance of Postoperative Subsyndromal Delirium.

Authors:  Jewel Shim; Glen DePalma; Laura P Sands; Jacqueline M Leung
Journal:  Psychosomatics       Date:  2015-05-15       Impact factor: 2.386

4.  Understanding international differences in terminology for delirium and other types of acute brain dysfunction in critically ill patients.

Authors:  A Morandi; P Pandharipande; M Trabucchi; R Rozzini; G Mistraletti; A C Trompeo; C Gregoretti; L Gattinoni; M V Ranieri; L Brochard; D Annane; C Putensen; U Guenther; P Fuentes; E Tobar; A R Anzueto; A Esteban; Y Skrobik; J I F Salluh; M Soares; C Granja; A Stubhaug; S E de Rooij; E Wesley Ely
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

5.  Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: the multinational AID-ICU inception cohort study.

Authors:  Marie O Collet; Jesús Caballero; Romain Sonneville; Fernando A Bozza; Peter Nydahl; Anna Schandl; Hilden Wøien; Giuseppe Citerio; Mark van den Boogaard; Johanna Hästbacka; Matthias Haenggi; Kirsten Colpaert; Louise Rose; Marija Barbateskovic; Theis Lange; Aksel Jensen; Martin B Krog; Ingrid Egerod; Helle L Nibro; Jørn Wetterslev; Anders Perner
Journal:  Intensive Care Med       Date:  2018-05-16       Impact factor: 17.440

6.  Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients.

Authors:  P P Pandharipande; A Morandi; J R Adams; T D Girard; J L Thompson; A K Shintani; E Wesley Ely
Journal:  Intensive Care Med       Date:  2009-07-09       Impact factor: 17.440

7.  Delirium in the ICU: an overview.

Authors:  Rodrigo Cavallazzi; Mohamed Saad; Paul E Marik
Journal:  Ann Intensive Care       Date:  2012-12-27       Impact factor: 6.925

8.  Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study.

Authors:  John W Devlin; Yoanna Skrobik; Richard R Riker; Eric Hinderleider; Russel J Roberts; Jeffrey J Fong; Robin Ruthazer; Nicholas S Hill; Erik Garpestad
Journal:  Crit Care       Date:  2011-09-17       Impact factor: 9.097

9.  Association Between Incident Delirium Treatment With Haloperidol and Mortality in Critically Ill Adults.

Authors:  Matthew S Duprey; John W Devlin; Johannes G van der Hoeven; Peter Pickkers; Becky A Briesacher; Jane S Saczynski; John L Griffith; Mark van den Boogaard
Journal:  Crit Care Med       Date:  2021-08-01       Impact factor: 9.296

Review 10.  Outcome of delirium in critically ill patients: systematic review and meta-analysis.

Authors:  Jorge I F Salluh; Han Wang; Eric B Schneider; Neeraja Nagaraja; Gayane Yenokyan; Abdulla Damluji; Rodrigo B Serafim; Robert D Stevens
Journal:  BMJ       Date:  2015-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.